​

Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?

OverviewForecastRevenueFinancialsChart

Ovid Therapeutics Ownership Summary

Ovid Therapeutics is owned by 18.24% institutional investors, 9.82% insiders, and 71.94% retail investors. Takeda pharmaceutical is the largest institutional shareholder, holding 10.59% of OVID shares. Federated Hermes Kaufmann Small Cap A is the top mutual fund, with 5.01% of its assets in Ovid Therapeutics shares.

OVID Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOvid Therapeutics18.24%9.82%71.94%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Takeda pharmaceutical7.53M10.59%$9.79M
Blackrock3.99M5.65%$3.07M
Federated hermes3.57M5.02%$5.31M
Vanguard group3.07M4.32%$5.01M
Affinity asset advisors2.65M3.73%$3.44M
Artal group2.50M3.54%$1.92M
Abel hall32.35K2.59%$10.67K
Renaissance1.48M2.09%$2.42M
Sio capital management1.43M2.01%$1.86M
Driehaus capital management1.40M1.97%$1.82M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical7.53M59.82%$9.79M
Tls advisors13.60K0.98%$374.00K
Sio capital management1.43M0.47%$1.86M
Affinity asset advisors2.65M0.30%$3.44M
Velan capital investment management lp160.00K0.20%$208.00K
Ikarian capital1.10M0.14%$1.42M
Awm investment company899.20K0.14%$1.47M
Diadema partners lp187.74K0.06%$244.06K
Artal group2.50M0.05%$1.92M
Persistent asset partners46.04K0.04%$59.85K

Top Buyers

HolderShares% AssetsChange
Federated hermes3.57M0.01%3.57M
Affinity asset advisors2.65M0.30%1.98M
Ikarian capital1.10M0.14%1.10M
Awm investment company899.20K0.14%899.20K
Schonfeld strategic advisors883.15K0.01%883.15K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---6.12M
Bvf inc/il---3.85M
Siren---2.85M
Madison avenue partners, lp---1.31M
Kennedy capital management---1.11M

New Positions

HolderShares% AssetsChangeValue
Federated hermes3.57M0.01%3.57M$5.31M
Ikarian capital1.10M0.14%1.10M$1.42M
Awm investment company899.20K0.14%899.20K$1.47M
Schonfeld strategic advisors883.15K0.01%883.15K$1.15M
Walleye capital596.72K0.00%596.72K$775.73K

Sold Out

HolderChange
Newedge advisors-4.00
True wealth design-8.00
Ifp advisors-8.00
Nelson, van denburg & campbell wealth management group-10.00
Frazier financial advisors-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202537-55.95%12,969,774-64.18%180.70%15-64.29%9-62.50%
Sep 30, 202526-62.86%6,077,081-83.10%80.33%13-60.61%8-61.90%
Jun 30, 202569-15.85%35,963,757-7.47%2,877297.56%3417.24%21-25.00%
Mar 31, 202583-46,400,658-2.45%370.83%29-21.62%2833.33%
Dec 31, 202428-63.16%10,144,389-73.85%140.48%13-69.05%7-53.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Federated Hermes Kaufmann Small Cap A3.57M5.01%3.57M
Vanguard Total Stock Mkt Idx Inv2.01M2.82%-
Vanguard US Total Market Shares ETF1.79M2.52%-
Kennedy Micro Cap1.04M1.46%-64.12K
Vanguard Institutional Extnd Mkt Idx Tr622.30K0.87%-
Fidelity Small Cap Index578.63K0.81%-
State St Russell Sm/Mid Cp® Indx NL Cl C525.80K0.74%-
State St Russell Sm/Mid Cp® Indx SL Cl I525.80K0.74%-
MEDICAL BioHealth EUR Acc503.85K0.71%-
Kennedy Micro Cap Opportunities465.48K0.65%82.64K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 23, 2026ALEXANDER MARGARET A. President and CEOSell$16.90K
Feb 23, 2026Rona Jeffrey A CBFOSell$12.38K
Dec 11, 2025LEVIN JEREMY M CEOBuy-
Dec 11, 2025LEVIN JEREMY M CEOBuy$66.27K
Dec 11, 2025LEVIN JEREMY M CEOBuy$49.70K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q43-
2025 Q112
2024 Q4--
2024 Q3--

OVID Ownership FAQ

Who Owns Ovid Therapeutics?

Ovid Therapeutics shareholders are primarily institutional investors at 18.24%, followed by 9.82% insiders and 71.94% retail investors. The average institutional ownership in Ovid Therapeutics's industry, Biotech Stocks , is 381.47%, which Ovid Therapeutics falls below.

Who owns the most shares of Ovid Therapeutics?

Ovid Therapeutics’s largest shareholders are Takeda pharmaceutical (7.53M shares, 10.59%), Blackrock (3.99M shares, 5.65%), and Federated hermes (3.57M shares, 5.02%). Together, they hold 21.26% of Ovid Therapeutics’s total shares outstanding.

Does Blackrock own Ovid Therapeutics?

Yes, BlackRock owns 5.65% of Ovid Therapeutics, totaling 3.99M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.07M$. In the last quarter, BlackRock decreased its holdings by -203K shares, a -4.84% change.

Who is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested, with 59.82% of its assets in 7.53M Ovid Therapeutics shares, valued at 9.79M$.

Who is the top mutual fund holder of Ovid Therapeutics shares?

Federated Hermes Kaufmann Small Cap A is the top mutual fund holder of Ovid Therapeutics shares, with 5.01% of its total shares outstanding invested in 3.57M Ovid Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools